93 7220 (Topiramate 200 mg)

Pill imprint 93 7220 has been identified as Topiramate 200 mg.

Topiramate is used in the treatment of obesity; bipolar disorder; migraine prevention; fibromyalgia; trigeminal neuralgia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93 7220

Topiramate 200 mg 93 7220
Topiramate 200 mg 93 7220
Topiramate 200 mg 93 7220
Topiramate
Imprint:
93
7220
Strength:
200 mg
Color:
Pink
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-7220
Inactive Ingredients:
silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
corn starch
titanium dioxide
hypromelloses
polydextrose
ferric oxide red
FD&C Red No. 40
FD&C Blue No. 2
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68071-0181 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)